🔎 Trials Near Me

Dachaigh › Ailseachadh nan Sgamhan › Texas › Irving

Sgrùdaidhean clionaigeach Ailseachadh nan Sgamhan ann an Irving, TX

Tha 6 sgrùdaidhean airson Ailseachadh nan Sgamhan a’ lorg phàirtichean aig làraichean ann agus timcheall air Irving (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A’ fastadhÌre 3
  • US Oncology Investigational Products Center (IPC), Irving
  • US Oncology Investigational Products Center, Irving
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07222566

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • NEXT Oncology - Irving, Irving
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06618287

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

A’ fastadhÌre 1/2
  • NEXT Dallas, Irving
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

A’ fastadhÌre 1/2
  • NEXT Oncology Dallas, Irving
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06162221

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

A’ fastadhÌre 1/2
  • NEXT Dallas, Irving
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT06922591

Sgrùdaidhean Ailseachadh nan Sgamhan ann am bailtean eile

Sgrùdaidhean eile ann an Irving

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.